001     877282
005     20220930130241.0
020 _ _ |a 978-3-95806-480-5
024 7 _ |2 Handle
|a 2128/25338
024 7 _ |2 URN
|a urn:nbn:de:0001-2020072314
024 7 _ |2 ISSN
|a 1866-1807
037 _ _ |a FZJ-2020-02105
041 _ _ |a English
100 1 _ |0 P:(DE-Juel1)168455
|a Milke, Lars
|b 0
|e Corresponding author
|g male
|u fzj
245 _ _ |a Engineering of Corynebacterium glutamicum towards increased malonyl-CoA availability for polyketide synthesis
|f 2017-01-01 - 2020-05-18
260 _ _ |a Jülich
|b Forschungszentrum Jülich GmbH Zentralbibliothek, Verlag
|c 2020
300 _ _ |a IX, 117 S.
336 7 _ |2 DataCite
|a Output Types/Dissertation
336 7 _ |0 PUB:(DE-HGF)3
|2 PUB:(DE-HGF)
|a Book
|m book
336 7 _ |2 ORCID
|a DISSERTATION
336 7 _ |2 BibTeX
|a PHDTHESIS
336 7 _ |0 2
|2 EndNote
|a Thesis
336 7 _ |0 PUB:(DE-HGF)11
|2 PUB:(DE-HGF)
|a Dissertation / PhD Thesis
|b phd
|m phd
|s 1595832391_14593
336 7 _ |2 DRIVER
|a doctoralThesis
490 0 _ |a Schriften des Forschungszentrums Jülich. Reihe Schlüsseltechnologien / Key Technologies
|v 223
500 _ _ |a Biotechnologie 1
502 _ _ |a Heinrich-Heine-Universität Düsseldorf, Diss., 2020
|b Dr.
|c Heinrich-Heine-Universität Düsseldorf
|d 2020
520 _ _ |a Polyketides are a structurally highly diverse group of natural products with interesting healthpromoting effects on humans. Despite all structural differences, polyketides are synthesized from simple CoA-activated carboxylic acid derivatives, such as acetyl-CoA or malonyl-CoA following a mechanism closely related to fatty acid biosynthesis. Unfortunately, polyketides are only synthesized in small quantities by the respective native organism. In contrast, microbial polyketide synthesis using engineered bacteria is a promising approach to get access to the desired products. Against this background, $\textit{Corynebacterium glutamicum}$ strains for the production of different plant polyketides such as stilbenes and flavonoids have been constructed recently. However, it soon became evident that the intracellular availability of malonyl-CoA is limiting the overall product formation in these strains. Hence, the main goal of this thesis was to optimize the intracellular malonyl-CoA availability in $\textit{C. glutamicum}$ by metabolic engineering. Additionally, the tailored strains should be used for establishing synthesis of biotechnological interesting polyketides. The following results were obtained: 1) Reduction of the citrate synthase activity to 5.5 % compared to the $\textit{C. glutamicum}$ wild type by exchanging the promotor of the encoding $\textit{gltA}$ gene, reduced acetyl-CoA consumption via the tricarboxylic acid cycle, which in turn improved malonyl-CoA availability. Upon transcriptional deregulation of $\textit{accBC}$ and $\textit{accD1}$ encoding the two subunits of acetyl-CoA carboxylase, malonyl-CoA synthesis from acetyl-CoA was drastically improved allowing for the synthesis of 65 mg/L (0.24 mM) naringenin und 450 mg/L (1.97 mM) resveratrol. Furthermore, improving the glucose uptake and elimination of anaplerotic pyruvate carboxylation reaction further contributed to an improved intracellular malonyl-CoA availability in the ultimately constructed strain $\textit{C. glutamicum}$ M-CoA. 2) Through episomal expression of genes encoding heterologous type III polyketide synthases from various plant species in the constructed strain $\textit{C. glutamicum}$ M-CoA, microbial synthesis of a pentaketide (noreugenin) but also phenylbutanoids (raspberry ketone, zingerone, benzylacetone) with a $\textit{ldhA}$-deficient variant could be established. The respective strains allowed for the synthesis of up to 53.3 mg/L (0.28 mM) noreugenin, 100 mg/L (0.61 mM) raspberry ketone, 70 mg/L (0.36 mM) zingerone and 10.5 mg/L (0.07 mM) benzylacetone from simple precursor molecules, respectively. 3) Hitherto, only type III polyketides can be synthesized by engineered $\textit{C. glutamicum}$ strains. In the context of this study, functional expression of a codon-optimized gene variant encoding the type I polyketide synthase 6-methylsalicylic acid synthase ChlB1 from $\textit {Streptomyces antibioticus}$ of 1,756 amino acids size was achieved. This allowed for the synthesis of up to 41 mg/L (0.27 mM) 6-methylsalicylic acid. It was found that $\textit{C. glutamicum}$ has an endogenous phosphopantetheinyltransferase activity, which can post-translationally activate ChlB1. This makes $\textit{C. glutamicum}$ a promising host for the production of other interesting type I polyketides.
536 _ _ |0 G:(DE-HGF)POF3-581
|a 581 - Biotechnology (POF3-581)
|c POF3-581
|f POF III
|x 0
856 4 _ |u https://juser.fz-juelich.de/record/877282/files/Schluesseltech_223.pdf
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/877282/files/Schluesseltech_223.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:877282
|p openaire
|p open_access
|p urn
|p driver
|p VDB
|p dnbdelivery
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)168455
|a Forschungszentrum Jülich
|b 0
|k FZJ
913 1 _ |0 G:(DE-HGF)POF3-581
|1 G:(DE-HGF)POF3-580
|2 G:(DE-HGF)POF3-500
|3 G:(DE-HGF)POF3
|4 G:(DE-HGF)POF
|a DE-HGF
|b Key Technologies
|l Key Technologies for the Bioeconomy
|v Biotechnology
|x 0
914 1 _ |y 2020
915 _ _ |0 StatID:(DE-HGF)0510
|2 StatID
|a OpenAccess
915 _ _ |0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
|a Creative Commons Attribution CC BY 4.0
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)IBG-1-20101118
|k IBG-1
|l Biotechnologie
|x 0
980 _ _ |a phd
980 _ _ |a VDB
980 _ _ |a book
980 _ _ |a I:(DE-Juel1)IBG-1-20101118
980 _ _ |a UNRESTRICTED
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21